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We need to know if there is an interest in an Immunization class in mid-summer of 2017.





 Pharmacy prices vary widely for generic heart drugs
 ASPIRIN  Study: Benefits of Daily Aspirin Outweigh
Gastrointestinal Risk
 DIABETES Steroids and Statins Tied to Increased Diabetes
Risk in RA
 Express Scripts Sees No Let-up in Drug Pricing Chatter
 Lilly to Offer Insulin at Discounted Prices to Certain
Patients
 Big Price Hikes Seen in Drug That Prevents Overdose
Deaths
 FDA Proposes the Removal and Addition of Substances to
Its 503A Bulks List
 Mylan launches generic EpiPen
 New Drug Review: Spinraza
 Addressing the Opioid Epidemic: Keeping Medicare and
Medicaid Beneficiaries Healthy
HOSPITAL
 Hospital Impact: Drug companies win, patients lose with
21st Century Cures Act




 FDA Approves Abuse-Deterrent Opioid, Vantrela ER
 FDA Updates Opioid Drug Label Information
 FDA APPROVALS Eucrisa Approved for Atopic Dermatitis
 FDA Approves New Treatment Option for Eczema
 FDA Bans Powdered Gloves
 FDA Approvals
 FDA Approves New Long-Acting Opioid for Severe Pain
 FDA Approves New Abuse-Deterrent Opioid
IMMUNIZATIONS
 ACIP Vaccine Recommendations
 Human trials of Zika vaccine underway
 Vaccinate Adults
 Vaccines for Children Program (VFC)
 Flu Activity on the Rise; CDC recommends vaccination
and appropriate use of antivirals
 Immunization Works Newsletters
 CDC Vaccine Price List
 How Does Ethnicity Affect Influenza Vaccine Responses?
INSURANCE
NEWS
 DIABETES Study: Light Walking Could Significantly
Improve Insulin Sensitivity In Diabetes Patients
 Study Details Effect of Nut Consumption on Risk of
Various Diseases
 PCP Patient Volume Linked to Diabetes Care Quality
 On-Demand Webcast Addressing Barriers to Top Quality
Diabetes Care in 2016 (CME/CNE/CPE)
 In Dementia, Care From Multiple Health Systems Poses
Drug Safety Risks
 Hepatitis C Virus Treatments and Screening
 Study: Chocolate Consumption Decreases Risk of
Diabetes
 Multistate Outbreak of Bloodstream Infections Due to
Contaminated Prefilled Saline Flush Syringes
 7 trends that will disrupt and define retail in 2017
 Find Government Services and Information Quickly
 CDC guides promote involvement of pharmacists to
manage hypertension




12/28/2016 Duravet Duramycin-10 Soluble Powder Stability Failure Huvepharma, Inc
11/29/2016 Megajex Male Sex Enhancer Dietary Supplement Unapproved new drug MS Bionic, Inc
11/24/2016 CVS and Kids Relief Homeopathic products Misdeclared Belladonna extract levels Raritan Pharmaceuticals
11/18/2016 Tri-Coast Pharmacy Inc. Sterile drug products Concern for lack of sterility assurance Tri-Coast Pharmacy Inc.
11/18/2016 Cantrell Drug Company Sterile drug products Concern for Lack of Sterility Assurance Cantrell Drug Company
SHORTAGES
Acetohydroxamic Acid (Lithostat) Tablets Currently in Shortage
Alitretinoin (Panretin) Gel Currently in Shortage
Ammonium Chloride Injection Currently in Shortage
Anagrelide Hydrochloride Capsules Resolved
Asparaginase Erwinia Chrysanthemi (Erwinaze) Currently in Shortage
Atropine Sulfate Injection Currently in Shortage
Bleomycin Sulfate for Injection Currently in Shortage
Caffeine Anhydrous (125mg/mL); Sodium Benzoate (125mg/mL) Injection Currently in Shortage
Calcium Chloride Injection, USP Currently in Shortage
Calcium Gluconate Injection Currently in Shortage
Cefepime Injection Currently in Shortage
Cefotaxime Sodium (Claforan) Injection Currently in Shortage
Cefotetan Disodium Injection Currently in Shortage
Ceftazidime and Avibactam (AVYCAZ) for Injection, 2.5g Currently in Shortage
Chloramphenicol Sodium Succinate Injection Resolved
Chloroquine Phosphate Tablets Resolved
Desmopressin Acetate Injection Resolved
Dexamethasone Sodium Phosphate Injection Currently in Shortage
Dextrose 5% Injection Bags Resolved
Dextrose Injection USP, 70% Resolved
Dihydroergotamine Mesylate Injection Currently in Shortage
Disopyramide Phosphate (Norpace) Capsules Currently in Shortage
Doxorubicin (Adriamycin) Injection Resolved
Doxorubicin Lyophilized Powder for Injection Currently in Shortage
Epinephrine Injection Currently in Shortage
Estradiol Valerate Injection, USP Currently in Shortage
Ethiodized Oil (Lipiodol) Injection Currently in Shortage
Etoposide Phosphate (Etopophos) Injection Currently in Shortage
Fentanyl Citrate (Sublimaze) Injection Currently in Shortage
Fomepizole Injection Currently in Shortage
Gemifloxacin Mesylate (Factive) Tablets Currently in Shortage
Hydroxyamphetamine Hydrobromide/Tropicamide (Paremyd) Currently in Shortage
Imipenem and Cilastatin for Injection, USP Currently in Shortage
Indigotindisulfonate Sodium (Indigo Carmine) Injection Currently in Shortage
Ketoprofen Capsules Resolved
L-Cysteine Hydrochloride Injection Currently in Shortage
Leucovorin Calcium Lyophilized Powder for Injection Currently in Shortage
Leuprolide Acetate Injection Resolved
Lidocaine Hydrochloride (Xylocaine) Injection Currently in Shortage
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LifeCare PCA™ Sterile Empty Vial and Injector Resolved
Liotrix (Thyrolar) Tablets Currently in Shortage
Mecasermin [rDNA origin] (Increlex) Injection Currently in Shortage
Methyldopate Hydrochloride Injection Currently in Shortage
Methylprednisolone Sodium Succinate for Injection, USP Currently in Shortage
Morphine Sulfate Injection, USP, CII, (Preservative-Free)(For PCA Use Only) Resolved
Multi-Vitamin Infusion (Adult and Pediatric) Currently in Shortage
Mupirocin Calcium Nasal Ointment Currently in Shortage
Nimodipine (Nymalize) Oral Solution Currently in Shortage
Nitrous Oxide, Gas Currently in Shortage
Penicillin G Benzathine (Bicillin L-A) Injection Currently in Shortage
Penicillin G Benzathine and Penicillin G Procaine (Bicillin C-R) Injection Currently in Shortage
Penicillin G Procaine Injection Currently in Shortage
Peritoneal Dialysis Solutions Currently in Shortage
Piperacillin and Tazobactam (Zosyn) Injection Currently in Shortage
Potassium Chloride Injection Currently in Shortage
Procainamide Hydrochloride Injection, USP Currently in Shortage
Ranitidine Injection, USP Currently in Shortage
Sacrosidase (Sucraid) Oral Solution Currently in Shortage
Scopolamine (Transderm Scop) Transdermal System Patch Currently in Shortage
Sodium Acetate Injection, USP Currently in Shortage
Sodium Bicarbonate Injection, USP Resolved
Sodium Chloride 0.9% Injection Bags Currently in Shortage
Sodium Chloride 23.4% Injection Currently in Shortage
Sufentanil Citrate (Sufenta) Injection Currently in Shortage
Sumatriptan (Imitrex) Nasal Spray Currently in Shortage
Technetium Tc99m Succimer Injection (DMSA) Currently in Shortage
Theophylline Extended Release Tablets and Capsules Currently in Shortage
Tigecycline (Tygacil) Injection Currently in Shortage
Tobramycin Injection Currently in Shortage
Tretinoin Capsules Resolved
Trimipramine Maleate (SURMONTIL) Capsules Currently in Shortage
Vancomycin Hydrochloride for Injection, USP Resolved




 Pharmacy prices vary widely for generic heart drugs
o http://drugtopics.modernmedicine.com/drug-topics/news/pharmacy-prices-vary-widely-generic-heart-drugs
 ASPIRIN  Study: Benefits of Daily Aspirin Outweigh Gastrointestinal Risk
o http://www.consultant360.com/exclusives/study-benefits-daily-aspirin-outweigh-gastrointestinal-risk
 DIABETES Steroids and Statins Tied to Increased Diabetes Risk in RA
o http://www.managedhealthcareconnect.com/content/steroids-and-statins-tied-increased-diabetes-risk-ra
 Express Scripts Sees No Let-up in Drug Pricing Chatter
o http://www.managedhealthcareconnect.com/content/express-scripts-sees-no-let-drug-pricing-chatter
 Lilly to Offer Insulin at Discounted Prices to Certain Patients
o http://www.managedhealthcareconnect.com/content/lilly-offer-insulin-discounted-prices-certain-patients
 Big Price Hikes Seen in Drug That Prevents Overdose Deaths
o http://www.managedhealthcareconnect.com/content/big-price-hikes-seen-drug-prevents-overdose-deaths
 FDA Proposes the Removal and Addition of Substances to Its 503A Bulks List
o http://www.pharmacytimes.com/product-news/fda-proposes-the-removal-and-addition-of-substances-to-its-503a-bulks-list
 Mylan launches generic EpiPen
o http://www.drugstorenews.com/article/mylan-launches-generic-epipen?tp=i-H55-Q5U-2Oi-3cVY4-1v-wGU-1c-WnO-3cUA6-
1tCY9i&utm_campaign=Generics&utm_source=Experian&utm_medium=email&cid=9220&mid=53506748













 Hospitals Affiliated with Medicare ACOs Decreased Readmission Rates Faster
o http://www.managedhealthcareconnect.com/content/hospitals-affiliated-medicare-acos-dropped-readmission-rates-faster
 CMS NEWS
o Pennsylvania Rural Health Model aims to help rural hospitals improve quality, address community health needs
Today, the Centers for Medicare & Medicaid Services (CMS) and Pennsylvania announced the Pennsylvania Rural Health Model, a
new initiative of the CMS Center for Medicare and Medicaid Innovation (Innovation Center). The Model is designed to improve
health and health care in rural Pennsylvania under an agreement signed by Governor Tom Wolf and Pennsylvania Secretary of
Health Karen Murphy.
Specifically, the Model seeks to increase rural Pennsylvanians’ access to high-quality care and improve their health, while also
reducing the growth of hospital expenditures across payers, including Medicare, and increasing the financial viability of the state’s
rural hospitals to ensure continued access to care facilities. Pennsylvania, through its Department of Health, will be a key partner in
jointly administering this model with CMS.
Under this model, participating rural hospitals will receive all-payer global budgets—or a fixed amount of money that is set in
advance and funded by all participating payers—to cover the inpatient and outpatient services they provide. Rural hospitals will use
this predictable funding to deliberately redesign the care they deliver to improve quality and meet the health needs of their local
communities.
The Model is open to critical access hospitals and acute care hospitals in rural Pennsylvania. In addition, other payers covering
individuals in the Commonwealth, including Medicaid and commercial health plans, are eligible to participate in the model by paying
participating rural hospitals through global budgets.
“The Pennsylvania Rural Health Model presents a historic opportunity for rural hospitals. We believe the hospitals will be able to
improve the quality of care they provide to their patients, and will also help address the underlying health needs in their
communities,” said Patrick Conway, M.D., CMS Principal Deputy Administrator and Chief Medical Officer. “The Model will help rural
hospitals remain financially viable and continue to provide essential services to the people in their communities.”
CMS intends to provide Pennsylvania with $25 million, which is a portion of the funding to begin implementing the Pennsylvania
Rural Health Model. Pennsylvania will use this funding to operate the model, including data analytics, quality assurance, and
technical assistance to help rural hospital participants create and implement plans to improve quality of care and address the most
prevalent health needs in the communities they serve.
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The Pennsylvania Rural Health Model aims to build on CMS’ partnerships with states to deliver high-quality, innovative care. CMS
has partnered with 38 states and territories through the State Innovation Models Initiative to improve quality and population health,
and leverage state-based innovation. CMS has been partnering with Maryland since 2014 through the Maryland All-Payer Model to
shift hospital payments to global budgets that reward value over volume. In October 2016, CMS announced the Vermont All-Payer
Accountable Care Organization Model to build on the Maryland All-Payer Model by transforming care statewide, beyond the
hospital. Pennsylvania participated in the State Innovation Models Initiative as a Round 2 Design State, which has helped support the
development of the Pennsylvania Rural Health Model. The Pennsylvania Rural Health Model will provide valuable insight for other
opportunities for CMS to participate in state-driven, all-payer payment and care delivery transformation efforts that address the
challenges faced by rural providers.
The Pennsylvania Rural Health Model is possible as a result of the Affordable Care Act, which created the CMS Innovation Center to
test innovative payment and service delivery models to reduce program expenditures while preserving or enhancing the quality of
care for Medicare, Medicaid, and Children’s Health Insurance Program beneficiaries. The purpose of this innovation is to pay
hospitals and clinicians based on the quality, not quantity, of care they give patients. Today’s announcement is part of the broader
strategy to improve the health system by paying providers for what works, unlocking health care data, and finding new ways to
coordinate and integrate care to improve quality.
For more information on the Pennsylvania Rural Health Model, please view the Fact Sheet or visit the CMS website.
FDA
 FDA Approves Abuse-Deterrent Opioid, Vantrela ER
o http://www.consultant360.com/exclusives/fda-approves-abuse-deterrent-opioid-vantrela-er




 FDA APPROVALS Eucrisa Approved for Atopic Dermatitis
o http://www.managedhealthcareconnect.com/content/new-eczema-drug-now-available
 FDA Approves New Treatment Option for Eczema
o http://www.consultant360.com/exclusives/fda-approves-new-treatment-option-eczema









 FDA Approves New Abuse-Deterrent Opioid
o http://www.consultant360.com/exclusives/fda-approves-new-abuse-deterrent-opioid
IMMUNIZATIONS
 ACIP Vaccine Recommendations
o https://www.cdc.gov/vaccines/hcp/acip-recs/index.html








 Flu Activity on the Rise; CDC recommends vaccination and appropriate use of antivirals
o https://www.cdc.gov/flu/spotlights/flu-activity-rise-2016-2017.htm
 Immunization Works Newsletters
o https://www.cdc.gov/vaccines/news/newsltrs/imwrks/index.html
 CDC Vaccine Price List
o https://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/index.html




 DIABETES Study: Light Walking Could Significantly Improve Insulin Sensitivity In Diabetes Patients
o http://www.consultant360.com/exclusives/study-light-walking-could-significantly-improve-insulin-sensitivity-diabetes-patients
 Study Details Effect of Nut Consumption on Risk of Various Diseases
o http://www.consultant360.com/topic/nutrition
 PCP Patient Volume Linked to Diabetes Care Quality
o http://www.managedhealthcareconnect.com/content/pcp-patient-volume-linked-diabetes-care-quality
 On-Demand Webcast Addressing Barriers to Top Quality Diabetes Care in 2016 (CME/CNE/CPE)
o http://www.consultant360.com/cme
 In Dementia, Care From Multiple Health Systems Poses Drug Safety Risks
o http://www.managedhealthcareconnect.com/content/dementia-care-multiple-health-systems-poses-drug-safety-risks
 Hepatitis C Virus Treatments and Screening
o http://www.consultant360.com/content/hepatitis-c-virus-treatments-and-screening
 Study: Chocolate Consumption Decreases Risk of Diabetes
o http://www.consultant360.com/exclusives/recent-study-finds-chocolate-consumption-decreases-risk-diabetes-diagnosis
 Multistate Outbreak of Bloodstream Infections Due to Contaminated Prefilled Saline Flush Syringes
o http://www.managedhealthcareconnect.com/article/multistate-outbreak-bloodstream-infections-due-contaminated-prefilled-saline-
flush-syringes
 7 trends that will disrupt and define retail in 2017
o http://www.retaildive.com/news/7-trends-that-will-disrupt-and-define-retail-in-2017/433542/
 Find Government Services and Information Quickly
o https://www.usa.gov/
 CDC guides promote involvement of pharmacists to manage hypertension
o http://www.pharmacist.com/article/cdc-guides-promote-involvement-pharmacists-manage-hypertension
 Alzheimer's Disease: Untapped Potential for Pharmacy
o http://drugtopics.modernmedicine.com/drug-topics/news/alzheimers-disease-untapped-potential-
pharmacy?cfcache=true&ampGUID=EC22DC7A-8C9E-4231-BAFB-C4E25C30003B&rememberme=1&ts=19012017
